Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...